Skip to content

HALOZYME THERAPEUTICS, INC.: filings

Every HALOZYME THERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 2026501410001159036-26-000104
10-Q2026-05-11fiscal Q1 2026491030001159036-26-000068
10-K2026-02-17fiscal FY 2025531370001159036-26-000024
10-Q2025-11-03fiscal Q3 2025511410001159036-25-000045
10-Q2025-08-05fiscal Q2 2025501390001159036-25-000034
10-Q2025-05-06fiscal Q1 2025491010001159036-25-000026
10-K2025-02-18fiscal FY 2024531360001159036-25-000010
10-Q2024-10-31fiscal Q3 2024511410001159036-24-000050
10-Q2024-08-06fiscal Q2 2024511410001159036-24-000044
10-Q2024-05-07fiscal Q1 2024501030001159036-24-000037
10-K2024-02-20fiscal FY 2023521340001159036-24-000008
10-Q2023-11-06fiscal Q3 2023511410001159036-23-000057
10-Q2023-08-08fiscal Q2 2023511410001159036-23-000048
10-Q2023-05-09fiscal Q1 2023501020001159036-23-000039
10-K2023-02-21fiscal FY 2022531380001159036-23-000012
10-Q2022-11-08fiscal Q3 2022501400001159036-22-000059
10-Q2022-08-09fiscal Q2 2022501390001159036-22-000050
10-Q2022-05-10fiscal Q1 202245940001159036-22-000038
10-K2022-02-22fiscal FY 2021481270001159036-22-000014
10-Q2021-11-02fiscal Q3 2021451280001159036-21-000050
10-Q2021-08-09fiscal Q2 2021431240001159036-21-000043
10-Q2021-05-10fiscal Q1 202143900001159036-21-000038
10-K2021-02-23fiscal FY 2020501870001159036-21-000014
10-Q2020-11-02fiscal Q3 2020441270001159036-20-000044
10-Q2020-08-10fiscal Q2 2020431250001159036-20-000037
10-Q2020-05-11fiscal Q1 202043930001159036-20-000030
10-K2020-02-24fiscal FY 2019501860001159036-20-000013
10-Q2019-11-12fiscal Q3 2019391100001159036-19-000060
10-Q2019-08-06fiscal Q2 2019391100001159036-19-000044
10-Q2019-05-07fiscal Q1 201943920001159036-19-000027
10-K2019-02-21fiscal FY 2018421690001159036-19-000006
10-Q2018-11-06fiscal Q3 2018391110001159036-18-000043
10-Q2018-08-07fiscal Q2 2018371030001159036-18-000037
10-Q2018-05-10fiscal Q1 201837750001159036-18-000031
10-K2018-02-20fiscal FY 2017421520001159036-18-000011
10-Q2017-11-07fiscal Q3 2017391100001159036-17-000045
10-Q2017-08-08fiscal Q2 2017371020001159036-17-000038
10-Q2017-05-09fiscal Q1 201735700001159036-17-000030
10-K2017-02-28fiscal FY 2016421370001159036-17-000014
10-Q2016-11-07fiscal Q3 201635960001159036-16-000133
10-Q2016-08-09fiscal Q2 2016371040001159036-16-000125
10-Q2016-05-09fiscal Q1 201633680001159036-16-000117
10-K2016-02-29fiscal FY 2015401310001159036-16-000100
10-Q2015-11-09fiscal Q3 201534910001159036-15-000092
10-Q2015-08-10fiscal Q2 2015391050001159036-15-000079
10-Q2015-05-11fiscal Q1 201535730001159036-15-000064
10-K2015-03-02fiscal FY 2014361160001159036-15-000041
10-Q2014-11-10fiscal Q3 201435890001159036-14-000093
10-Q2014-08-11fiscal Q2 201435890001159036-14-000070
10-Q2014-05-12fiscal Q1 201435720001159036-14-000042
10-K2014-02-28fiscal FY 2013361160001159036-14-000033
10-Q2013-11-08fiscal Q3 201335890001159036-13-000011
10-Q2013-08-07fiscal Q2 201335890001483813-13-000085
10-Q2013-05-08fiscal Q1 201335730001483813-13-000051
10-K2013-03-01fiscal FY 2012351120001483813-13-000033
10-Q2012-11-08fiscal Q3 201233860001193125-12-460700
10-Q2012-08-09fiscal Q2 201232820001193125-12-345733
10-Q2012-05-07fiscal Q1 201228560001193125-12-215311
10-K2012-03-12fiscal FY 201128740001193125-12-107555
10-Q2011-11-08fiscal Q3 201132850001193125-11-302232
10-Q2011-08-05fiscal Q2 201131840000950123-11-073693

Inspect the source

Entity
HALOZYME THERAPEUTICS, INC. / CIK 0001159036
Captured
2026-09-19T11:16:42.578Z
SEC response SHA-256
09ca2466c06425bbd1ba706e3a09155b9a42131078735be72a3a1bd471a407ac

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001159036.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))